KMD-3213, a novel 1A -adrenoceptor antagonist, potently inhibits the functional 1 -adrenoceptor in human prostate

By Moriyama N.   Akiyama K.   Murata S.   Taniguchi J.   Ishida N.   Yamazaki S.   Kawabe K.  

European Journal of Pharmacology, Vol. 331, Iss. 1, 1997-07 ,pp. : 39-42

Elsevier

Access to resources Recommend Favorite

Effect of JTH-601, a novel 1 -adrenoceptor antagonist, on prostate function in dogs

By Suzuki Y.   Kanada A.   Okaya Y.   Aisaka K.  

European Journal of Pharmacology, Vol. 394, Iss. 1, 2000-04 ,pp. : 123-130

Elsevier

Access to resources Recommend Favorite

The 1 -adrenoceptor antagonist, doxazosin, modulates the lower limit of autoregulation of cerebral blood flow during hemorrhagic hypotension in anesthetized hypertensive rats

By Cai H.   Ibayashi S.   Yao H.   Sugimori H.   Sadoshima S.   Fujishima M.  

European Journal of Pharmacology, Vol. 286, Iss. 3, 1995-11 ,pp. : 249-253

Elsevier

Access to resources Recommend Favorite

Inhibition of human ether-a-go-go-related gene potassium channels by α1-adrenoceptor antagonists prazosin, doxazosin, and terazosin

By Thomas Dierk   Wimmer Anna-Britt   Wu Kezhong   Hammerling Bettina   Ficker Eckhard   Kuryshev Yuri   Kiehn Johann   Katus Hugo   Schoels Wolfgang   Karle Christoph  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 5, 2004-05 ,pp. : 462-472

Springer Publishing Company

Access to resources Recommend Favorite

LK 204-545, a highly selective 1 -adrenoceptor antagonist at human -adrenoceptors

By Louis S.N.S.   Nero T.L.   Iakovidis D.   Jackman G.P.   Louis W.J.  

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 431-435

Elsevier

Access to resources Recommend Favorite